ARCA is a phosphorothioate (PS)-modified mRNA 7-methylguanosine (m7G) cap analog. ARCA-containing mRNAs had longer cellular half-lives and increased protein expression. β-S-ARCA (D1) has been used in the development of experimental mRNA-based anticancer vaccines.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
